champix – Are You On The Point Of No Return – Champix Offers More Gain And Less Pain
Are You On The Point Of No Return – Champix Offers More Gain And Less Pain
Champix Side Effects
Smoking cessation, with or without treatment, can result in various symptoms like:
Mood changes
Feeling of depression
Irritability
Frustration
Anxiousness
Difficulty sleeping
Difficulty concentrating
Decreased heart rate
Increased appetite
Weight gain
Minor Side Effects of Champix
Quit smoking medicines, including Champix can bring on certain side effects that affect individuals in different ways. This side effect may or may not be a direct side effect of using this medicine and may possibly be a result of giving up smoking. However, stating a side effect here, in no way, means that everybody using Champix will experience that very side effect.
Mentioned below are some of the common side effects that are known to be associated with using Champix that helps in smoking cessation. The side effects that affect 1 in 10 people are:
Nausea
Headache
Difficulty sleeping (insomnia)
Abnormal dreams
Sleepiness
Fatigue
Dizziness
Change in taste
Dry mouth
Disturbances of the gut such as:
Constipation
Diarrhoea
Vomiting
Abdominal discomfort or bloating
Indigestion
Flatulence
Increased appetite
Major Side Effects of Champix
Champix may also result in some not so common side effects that affect 1 in 1000 people approximately. These side effects are:
Decreased appetite
Inflammation of the:
Nose and throat (nasopharyngitis)
Sinuses (sinusitis)
Lungs (bronchitis)
Thirst
Shortness of breath, cough or hoarseness
Throat irritation
Runny nose
Snoring
Mood swings
Abnormal thinking
Changes in sex drive
Tremors
Abnormal co-ordination
Problems with speech
Restlessness or agitation
Palpitations or abnormal heartbeats
Abnormal intolerance to light
Skin reactions such as:
Rash
Itching
Sweating
Watery eyes
Increased urination
Chest pain
Increased blood pressure or hear
1000
t rate
Increased weight
Joint stiffness
Feeling cold
Other rare but serious side effects that have come to light fairly recently are:
Depression
Suicidal thoughts
Heart attack
Combining Champix with other medications may not be such a good idea. Therefore, when you are on Champix, you must consult a doctor before starting any new medication or stopping any medication as your Champix dose may need altering. The doctor must have complete information about all the prescription, over-the-counter and herbal medications you might be taking. This will ensure that the combination is safe for you.
Extensive studies have been conducted on combining Champix with other medications. Other smoking cessation medicines are therefore not recommended for use while on Champix. In addition, using nicotine replacement therapy (NRT) with Champix may bring on side effects like:
Nausea
Headache
Vomiting
Dizziness
Indigestion
Fatigue
Drop in blood pressure
Moreover, if you have severe kidney problems you must avoid taking drugs like Cimetidine in combination with Champix as this may increase the blood levels of Varenicline.
Likewise, the components in tobacco smoke have the potential to wash out medicines from the body at an above average pace. Similarly, if you are not smoking the same medicines are removed at a slower pace, causing the blood levels of Varenicline to increase. This means that your smoker or non-smoker status is going to be the deciding factor for most medicines you take. Medicines that can react with Champix are:
Clozapine
Dextropropoxyphene
Flecainide
Fluvoxamine
Olanzapine
Pentazocine
Phenylbutazone
Benzodiazepines like oxazepam
Beta-blockers like propranolol
Tacrine
Theophylline
Tricyclic antidepressants like imipramine
Warfarin
Smokers who suffer from diabetes normally need more insulin, as smoking reduces the amount of insulin that is absorbed into the blood from an injection under the skin.
Use of Champix is restricted in:
Pregnant women or women who plan on becoming pregnant
Children below the age of 18 years
Lactating mothers
People who are allergic to Champix ingredients
By: Anthony Delar
Article Directory: http://www.articledashboard.com
Webmaster associated with online clinic “HealthExpress” this site provides various information on Champix (Varenicline) and helps people in curing Smoking Cessation, resources are available on site HealthExpress.co.uk.
Click the XML Icon Above to Receive Medicine Articles Via RSS!
Additional Articles From – Home | Health & Fitness | Medicine
Impact of Rhinoplasty on Your Looks
Cold Symptoms : Know When to Give Medicine to your Child
Correct your Astigmastism with Toric Contact Lenses
Importance of Sports Nutrition in athlete’s life
What is Vitiligo?
Governor of Wisconsin Encourages Prescription Drugs Canada
Why Use A Natural Sleep Aid For Insomnia?
What Are Some Of The Symptoms of Hemorrhoids?
Want Extended Wear Contact Lenses For Astigmatism? Try ACUVUE Oasys
Online Pharmacy-Enable you to spend less money on medication
Smoking cessation drug’s link to depression countered – Yahoo! Canada News
Module body
Fri Oct 2, 2:20 PM
OTTAWA (CBC) – A newer smoking cessation drug is not linked to an increased risk of self-harm or depression, a British study suggests.
ADVERTISEMENT
Health Canada and the U.S. Food and Drug Administration have warned that people taking varenicline sold in Canada as Champix and in the U.S. as Chantix have experienced unusual feelings of agitation, depressed mood, hostility, changes in behaviour or impulsive or disturbing thoughts, such as ideas of self-harm or of harming others.
The smoking cessation product is effective. British researchers writing in Friday’s issue of the British Medical Journal looked for more evidence of adverse neuropsychiatric effects related to the drug.
The team analyzed information on 80,660 men and women, aged 18 to 95, who were prescribed a smoking cessation product between September 2006 and May 2008.
No clear evidence was found linking varenicline or bupropion to increased risk for self-harm, suicidal thoughts or depression, the researchers said.
“Although a twofold increased risk of self-harm with varenicline cannot be ruled out, these findings provide some reassurance concerning its association with suicidal behaviour,” the study’s authors concluded.
Among the study participants were prescribed smoking cessation products:
All electronic patient records over the period of the prescription and for three months after the date of the last prescription were examined for incidences of fatal and non-fatal self-harm, suicidal thoughts and depression.
The researchers recommended further study of varenicline’s effect on suicide risk in other databases and adverse event reports in clinical trials.
Any risks associated with varenicline must be balanced the long-term benefits of butting out and the drug’s effectiveness as a smoking cessation product, they added.
Champix has been approved since April 2007. Of the 818 complaints about Champix Health Canada had received complaints on its adverse reaction database, 520 involved psychiatric problems, CBC News reported in February.
From January to November 2008, nearly 1.1 million Champix prescriptions were dispensed from Canadian retail pharmacies, according to IMS Health Canada, which tracks the pharmaceutical industry.
The study was funded by Britain’s Medicines and Health Regulatory Agency.
Email Story
IM Story
Printable View
LATEST HEADLINES
Edmonton charity big winner in Battle of the Blades CBC
Shuttle Atlantis lifts off on space station stockpiling mission, launch crowd atwitter The Canadian Press
Skeletal Maori remains, discovered in boxes at Welsh museum, handed back to New Zealand The Canadian Press
Flu vaccine up to 3 weeks away for most in B.C. CBC
Australian doctors operate on conjoined twins CBC
Science News Archive
Push for Cdn content in TV/Cable battle Canadian Press
Arnie visits U.S. troops in Iraq Reuters
Palin-Palooza: Fmr. Gov. Takes Spotlight ABC
Champix varenicline is a prescription only smoking cessation aid that was first licensed for use in UK in December 2006. Developed by Pfizer pharmaceuticals, Champix has helped thousands of smokers quit smoking for life. Champix varenicline is rated better than other popular smoking cessation aids such as nicotine replacement therapy (NRT) as it does not contain nicotine and is therefore not addictive.
Champix varenicline mimics the effect of nicotine on the body and produces twin benefits of both reducing the urge to smoke and relieving patients of painful nicotine withdrawal symptoms. The FDA has approved the use of Champix, for a period of 12 weeks. During this period, Champix will help patients to get rid of their smoking habits. However, in some patients, even if smoking cessation has been achieved, the doctor may recommend Champix treatment for another 12 weeks so as to nullify any chances of a person’s getting back to smoking.
Proper use of Champix varenicline
To achieve your smoking cessation goal always use Champix varenicline on the advice of your doctor at the recommended dosage. Your doctor shall determine your Champix dosage based on the number of factors such as how you respond to Champix, other medications you may be taking and any medical conditions you may be suffering from.
Before beginning with the Varenicline treatment, you along with your doctor will choose a ‘quit date’ which is the day when you try to stop smoking. Your Champix treatment will begin a week before the quit date. During this one week you are free to quit. And, even after beginning with the treatment if you happen to smoke, do not discontinue Champix treatment and continue trying to quit.
Champix varenicline treatment is started with a low-dose of 0.5mg tablet once a day for 3 days. The dosage is the increased to 0.5mg tablet twice a day for next 4 days. After this, the recommended Champix dosage is 1mg tablet twice a day for the next 12 weeks. The purpose of gradually increasing Champix dosage is to reduce the chances of side effects of the drug such as nausea, unusual dreams etc.
To ensure proper use of Champix treatment, take Champix orally after food with a full glass of water. Take the medicine regularly, preferably at the same time(s) of the day as this will help you remember taking your dosage.
Do not alter the dosage without first consulting the doctor. Let your doctor know if you continue to smoke ever after a few weeks of treatment. In case you are successful in remaining smoke-free during the 12-weeks of the treatment, your doctor may recommend you another 12-week of Champix treatment to slim-down your chances of getting back to the cigarette.
Precautions to take before using Champix varenicline
Champix varenicline is a prescription only treatment and should never be taken on your own without first consulting a doctor. Listed here are necessary precautions to take before using Champix . Ensure that you follow the treatment so as to minimize the chances of getting side effects and successfully achieve your smoking cessation goal.
- Do not change your Champix varenicline dosage strengths without first consulting your doctor.
- Inform your doctor about your medical conditions and any type of prescription or OTC medicines that you may be taking.
- People with mental illness or history of suicidal behavior should not use Champix.
- Report to your doctor immediately in case you experience unusual changes in your behavior or if you have suicidal thoughts.
- Patients with serious kidney diseases such as kidney failure may need to take a lower Champix dosage, depending on the severity of the problem.
- Champix is not recommended for use in children and in women who are pregnant or breastfeeding.
Tests on Champix Varenicline
In clinical trials, Champix varenicline is proven to be a safe and effective drug. Studies have shown that people who take 12-week treatment of Champix quadruple their chance of quitting as compared to those taking placebo. Moreover, they are nearly twice likely to quit than those taking the other main anti-smoking drug treatment,Zyban (bupropion treatment).
Given below are the results of two independent studies conducted on Champix varenicline and Zyban:
- 44% of patients put on Champix varenicline quit smoking at 12 weeks as compared to 29.5% of those put on Zyban and 18% on a placebo.
- In the 9 to 52 week trial period, 22% of the patients on Champix varenicline remained smoke free while this figure was 16% for Zyban and only 8.4% for those on a placebo.
Katie writes article on Health related issue and medication. Among her many written articles one is on Champix Varenicline. smoking cessation drug Champix Varenicline that helps people in curing their addictions to smoking.
Mail this post
